Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | HPGD | P15428 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17228738 | 0.96 | MAPT (0.42) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12969344 | 0.92 | ALOX5 (0.46) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12968447 | 0.92 | ALOX5 (0.46) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12968431 | 0.90 | ALOX5 (0.46) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12799828 | 0.90 | MAPT (0.44) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12799862 | 0.90 | MAPT (0.44) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL17851235 | 0.89 | ALOX5 (0.51) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12969181 | 0.89 | HPRT1 (0.46) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12799824 | 0.89 | ALOX5 (0.47) | MAPTHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL12968451 | 0.87 | MEN1 (0.43) | MAPTHPGDALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796736-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20160083404-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083404-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CRY1, CCNE2, CCNE1 | MAPT 3716/4885HPGD 51/4885ALDH1A1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.